COMMUNIQUÉS West-GlobeNewswire

Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
01/04/2026
CAMBRIDGE, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced [...]
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
01/04/2026
MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional [...]
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
01/04/2026
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – April 1, 2026 – 10:05 [...]
Celldex Announces Proposed Public Offering of Common Stock
01/04/2026
HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced that it has commenced an underwritten public offering for the sale of shares of [...]
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
01/04/2026
CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham [...]
Berberine Weight Loss Patches by Purisaki Under Investigation (URGENT Warning Issued)
01/04/2026
Consumer Search Activity Surges as Questions Mount Over Berberine Patch Ingredients, Transdermal Delivery Claims, and Company Background — Publicly Available Information Compiled for 2026 Wayne, NJ, April 01, 2026 ( [...]
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
01/04/2026
Company Announcement COPENHAGEN, Denmark; April 1, 2026 – Genmab A/S (Nasdaq: GMAB) - This document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely [...]
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
01/04/2026
RenovoRx Joins the Ranks of Google, Nvidia, Adidas, Walmart, and More MOUNTAIN VIEW, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life-sciences company [...]
XORTX Confirms Effective Date of Share Consolidation
01/04/2026
CALGARY, Alberta, April 01, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on [...]
Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24
01/04/2026
CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the [...]
Ipsen announces the availability of its 2025 Universal Registration Document
01/04/2026
Ipsen announces the availability of its 2025 Universal Registration Document PARIS, FRANCE, 1 APRIL 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced that its 2025 Universal Registration Document has been filed today [...]
Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025
01/04/2026
Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025 PARIS, FRANCE, 1 er AVRIL 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce que son Document d’enregistrement universel 2025 a été [...]
From The Earth and Illicit Launch Golden Ticket Giveaway This 4/20 Weekend
01/04/2026
Ten Missouri cannabis consumers can win $1,000 in free product, a VIP factory tour, and entry into a $5,000 cash prize raffle KANSAS CITY, Mo., April 01, 2026 (GLOBE NEWSWIRE) -- From The Earth dispensaries and award- [...]
Roto-Rooter Completes Acquisitions for Two Significant Territories
01/04/2026
CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- On March 31, Roto-Rooter Services Company , a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE ) announced it has purchased the territory and assets of [...]
Origin Health Unveils Newly Redesigned Website and Announces Open Registration for 2nd Annual Guardian Initiative Charity Golf Tournament
01/04/2026
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Origin Modern Health & Wellness, a leader in integrative and regenerative healthcare, today announced the official launch of its newly redesigned website alongside open [...]
Lumina Therapy Alliance Expands to the Bay Area with Addition of San Francisco Stress and Anxiety Center, Approaching 400 Clinicians Nationwide
01/04/2026
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance , a national network of premier, in-person mental health practices, today announced that the San Francisco Stress and Anxiety Center has joined its [...]
Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
01/04/2026
Throughout 2026, in partnership with members, providers, and employers, Progyny will highlight a decade of innovation, expanded access, and industry-leading outcomes. NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over [...]
Extendicare Acquires CBI Home Health
01/04/2026
MARKHAM, Ontario, April 01, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced that its wholly-owned home health care subsidiary, ParaMed Inc. (“ ParaMed ” or the “ [...]
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
01/04/2026
TORONTO and HAIFA, Israel, April 01, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing exosome-based therapies [...]

Pages